Open AccessErythropoietin and Diabetic Retinopathy
Author(s) -
Francesco Semeraro
Publication year - 2013
Publication title -
journal of diabetes and metabolism
Language(s) - English
Resource type - Journals
ISSN - 2155-6156
DOI - 10.4172/2155-6156.1000283
Subject(s) - medicine , diabetic retinopathy , diabetes mellitus , erythropoietin , retinopathy , ophthalmology , optometry , endocrinology
Diabetic retinopathy (DR) is the main cause of visual impairment in industrialized countries. Great efforts are\udin place to search for new therapies able to prevent the development of DR and the onset of its complications.\udAt present, therapy consists of anti-VEGF intra vitreal injections and is aimed at preventing the main causes of\udvisual impairment, that is, macular oedema and retinal proliferation. However, the current knowledge has led us\udto hypothesize about the roles of other factors implicated in the pathogenesis of macular oedema and retinal\udproliferation; erythropoietin (EPO) is one such compound.\udThe aim of the work was to review the recent literature on the applications of EPO within the context of DR\udetiopathogenicit